• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Thyrocare Technologies Ltd.
    05 Jul 2023
    1301.60
    -2.23%
    Manipal Group offers to inject Rs 1,000 cr in PharmEasy owner API Holdings: Report
    Manipal Group offers to inject Rs 1,000 cr in PharmEasy owner API Holdings: Report
    Business Today
    It is important to note that API Holdings has to repay a debt of Rs 2,500 crore. Previously, the company had pledged the shares of its subsidiary Thyrocare to Goldman Sachs as collateral for this debt.
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologies Ltd. is trading below its 30 day SMA of 1312.8
    logo
    Dr. Lal Pathlabs Ltd.
    28 Jun 2023
    Analyst Hold Insider Trades
    3337.60
    3.39%
    Dr Lal PathLabs, Metropolis and Thyrocare: Why shares underperformed last year and should you buy now?
    Business Line
    Price hikes undertaken by companies has resulted in some bounce in shares in recent weeks
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas increased Hold price target of Dr. Lal Pathlabs Ltd. to 3548.0 on 02 Sep, 2025.
    logo
    Dr. Lal Pathlabs Ltd.
    21 Jun 2023
    Analyst Hold Insider Trades
    3337.60
    3.39%
    Trade Spotilght | How to trade in Shriram Finance, Balkrishna Industries, Dr Lal Path Labs
    Trade Spotilght | How to trade in Shriram Finance, Balkrishna Industries, Dr Lal Path Labs
    Moneycontrol
    Dr Lal PathLabs has maintained upward journey for third consecutive session, rising 4.8 percent to Rs 2,223 on Tuesday. In fact, it has given a close above 200-day EMA (exponential moving average - Rs 2,141), which is a positive sign.
    Copy LinkShare onShare on Share on Share on
    Dr. Lal Pathlabs Ltd. has gained 42.04% in the last 6 Months
    logo
    Thyrocare Technologies Ltd.
    20 Jun 2023
    1301.60
    -2.23%
    Thyrocare spurts after 5% equity changes hands
    Thyrocare spurts after 5% equity changes hands
    Moneycontrol
    The deal comes two weeks after the company met with Artisan Partners and Grandeur Peak Global Fund
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.
    logo
    Dr. Lal Pathlabs Ltd.
    20 Jun 2023
    Analyst Hold Insider Trades
    3337.60
    3.39%
    Trade Spotlight | Your strategy for MM Financial Services, eClerx Services, Dr Lal PathLabs
    Trade Spotlight | Your strategy for MM Financial Services, eClerx Services, Dr Lal PathLabs
    Moneycontrol
    Dr Lal PathLabs has given a breakout of Mother candle of May 12 with bullish candlestick pattern formation and significantly higher volumes. The stock has touched 200-day EMA (Rs 2,140) intraday and finally settled at Rs 2,121, up 4.7 percent.
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas increased Hold price target of Dr. Lal Pathlabs Ltd. to 3548.0 on 02 Sep, 2025.
    logo
    Thyrocare Technologies Ltd.
    09 Jun 2023
    1301.60
    -2.23%
    Nomura India's head of investment banking steps down
    Nomura India's head of investment banking steps down
    Business Today
    During his tenure at the company, Oza played a key role in various deals, including Nomura's sale of ASK Group to Blackstone and the sale of diagnostics firm Thyrocare to healthcare firm PharmEasy.
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologies Ltd. is trading above its 200 day SMA of 953.9
    Nomura India's Head of Investment Banking Utpal Oza steps down: Report
    Business Standard | 08 Jun 2023
    logo
    Kovai Medical Center and Hospital Ltd.
    06 Jun 2023
    6349.65
    0.15%
    Vegetable and fruit retail too hot for private equity firm
    Business Line
    WestBridge Capital picked up an undisclosed stake in Coimbatore-based KPN Farm Fresh, which runs Kovai Pazhamudir Nilayam outlets, for 600 crore
    Copy LinkShare onShare on Share on Share on
    Kovai Medical Center and Hospital Ltd. is trading above all available SMAs
    logo
    Thyrocare Technologies Ltd.
    23 May 2023
    1301.60
    -2.23%
    Thyrocare Technologies Q4 earnings: Net profit tumbles 36% to 21 Cr, revenue up 4%
    Thyrocare Technologies Q4 earnings: Net profit tumbles 36% to 21 Cr, revenue up 4%
    livemint
    During Tuesday's closing session, Thyrocare Technologies, a small-cap firm, registered a market cap of 2,487.45 Cr.
    Copy LinkShare onShare on Share on Share on
    Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.
    logo
    Metropolis Healthcare Ltd.
    19 May 2023
    2208.60
    1.47%
    Buy Metropolis Healthcare; target of Rs 1520: YES Securities
    Buy Metropolis Healthcare; target of Rs 1520: YES Securities
    Moneycontrol
    YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated May 17, 2023.
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcare Ltd. is trading above all available SMAs
    logo
    Metropolis Healthcare Ltd.
    17 May 2023
    2208.60
    1.47%
    AI cannot replace human knowledge: Metropolis Healthcare Promoter & MD
    AI cannot replace human knowledge: Metropolis Healthcare Promoter & MD
    Business Standard
    In 2021-22, Covid19 business was almost 20-22% of the revenue for most diagnostic companies. The non-Covid19 business is not going to grow by 22% to make it equal
    Copy LinkShare onShare on Share on Share on
    Metropolis Healthcare Ltd. has gained 28.97% in the last 3 Months
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd